الفهرس | Only 14 pages are availabe for public view |
Abstract The introduction of parenterally administered drugs in the obstetric population encounters many challenges. Such obstacles are imperative, as careless systemic administration of any medication may have a profound effect on both mother and fetus. Dexmedetomidine use in obstetric analgesia is being explored in view of its high lipophilicity. It is retained in the placental tissue, thereby resulting in less fetal transfer and a decreased incidence of fetal bradycardia |